AKT1 and melanoma: The above results seem to be particularly important from the perspective of future application of EA or OeB in skin cancer treatment because PI3K/Akt and also mitogen-activated protein kinase (MAPK) pathways seem to be an attractive target in anti-melanoma therapy [93].